To fully understand the biological relevance of a particular glycan in a glycoconjugate one needs to elucidate the primary sequence and subsequent structure. Minor changes in carbohydrate structure can greatly influence the bioactivity of a particular glycoprotein. The high diversity of glycosylation makes structural elucidation very difficult and in most cases a combination of orthogonal methods is used for an accurate glycan profile. Frequently used analytical methods for the structural analysis of complex carbohydrates includes capillary electrophoresis (CE), mass spectrometry (MS) and high-performance liquid chromatography (HPLC), often combined with exoglycosidase digestion techniques.
- Sequencing glycans typically begins with the release of the N-linked carbohydrate moieties from the glycoprotein using an endoglycosidase, such as PNGase F.
- Free glycans can be analyzed directly, but they are often derivatized with fluorescent markers, such as 2-aminobenzamine (2AB), or with methyl groups (permethylation) to increase the sensitivity of detection, which is essential to observe low abundance glycan species.
- Modified glycans can be analyzed by mass spectrometry, and putative structures can be assigned based on the mass spectral data.
- Exoglycosidases can be used to elucidate ambiguous structures in a glycan profile. Most exoglycosidases are specific for the sugar and the anomericity (α or β) of the linkage that they will recognize and cut. The researcher can use specific exoglycosidases to determine the anomericity and the type of terminal sugar residues present on the glycan being analyzed.
- Do detergents inhibit exoglycosidases/endoglycosidases?
- Can I fluorescently label a glycan released with endoglycosidases?
- Can I fluorescently label an O-glycan released by beta-elimination?
- What are the advantages of enzymatic deglycosylation?
- What are the best techniques to analyze N- and O-glycans?
- Detailed Characterization of Antibody Glycan Structure using the N-Glycan Sequencing Kit
- Characterization of Glycans from Erbitux®, Rituxan® and Enbrel® using PNGase F (Glycerol-free), Recombinant
- Unbiased and fast IgG deglycosylation for accurate N-glycan analysis using Rapid PNGase F
- NEBNext® Enzymatic Methyl-seq (EM-seq™)
Using Glycosidases to Remove Trim or Modify Glycans on Therapeutic Protein
N-Glycan Composition Profiling for Quality Testing of Biotherapeutics
This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).
While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.
For more information about commercial rights, please email us at firstname.lastname@example.org.
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.